References for Week 5,  Psychiatric Diseases  
Add references, including links to [Open-access journals](http://en.wikipedia.org/wiki/Open-access_journal) and articles for items that are mentioned in the course.  

Week 5,  Psychiatric Diseases


# Major Depressive Disorder Introduction to Psychiatric Disease   (40)  

---


# Major Depressive Disorder Unipolar Depressive Disorder Clinical description and genetics (41)  

**Serotonin transporter (SERT) mutations are linked to**
* [Murphy et al., Neuropharm, 2008](http://intramural.nimh.nih.gov/lcs/misc/sertpub-01.pdf) open-access [PubMed abstract](http://www.ncbi.nlm.nih.gov/pubmed/18824000)  
* Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Review. PubMed PMID: 18824000; PubMed Central PMCID: PMC2730952.

---

# Major Depressive Disorder Pathophysiology, Animal Models, (Biomarkers) (42)  

**Brain Areas that Regulate Mood**    
* [PubMed abstract of Berton and Nestler, Nature Revs Neurosci, 2006](http://www.ncbi.nlm.nih.gov/pubmed/16429123) semi open-access [available free if you register at Nature](http://www.nature.com/nrn/journal/v7/n2/full/nrn1846.html)  
* Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006 Feb;7(2):137-51. Review. PubMed PMID:16429123.  

**Serotonin transporter (SERT) knockout mice**  
* [Daws & Gould, Pharmacol. Therap. 2011 ](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131109/pdf/nihms290884.pdf) open-access  [PubMed abstract](http://www.ncbi.nlm.nih.gov/pubmed/21447358)  
* Daws LC, Gould GG. Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacol Ther. 2011 Jul;131(1):61-79. doi: 10.1016/j.pharmthera.2011.03.013. Epub 2011 Apr 5. Review. PubMed PMID: 21447358; PubMed Central PMCID: PMC3131109.

Fox et al., Psychopharmacol, 2007;  

---

# Major Depressive Disorder Mechanisms of antidepressant action  (43)  

---


# Major Depressive Disorder Additional Antidepressant Mechanisms  (44)  

---  

# Bipolar Disorder (45) 

---



#  Bipolar Disorder. Heterozygote advantage  (46) 

---

# Bipolar Disorder. Drugs and Other Therapies   (47) 

---

# Schizophrenia Clinical Description; Genetics (48)


---

# Schizophrenia Pathophysiology.  A Century of Frustration (49)


---

# Schizophrenia Nongenetic contributions, Biomarkers, & Animal Models  (50)

**Animal models for schizophrenia**  
* [AJ Law et al, PNAS 2012](http://www.odonnell-lab.net/LawPNAS2012.pdf)  open-access via [O'Donnell lab at University of Maryland](http://www.odonnell-lab.net/index.html) [PubMed abstract]( http://www.ncbi.nlm.nih.gov/pubmed/22689948)  
* Law AJ, Wang Y, Sei Y, O'Donnell P, Piantadosi P, Papaleo F, Straub RE, Huang W, Thomas CJ, Vakkalanka R, Besterman AD, Lipska BK, Hyde TM, Harrison PJ, Kleinman JE, Weinberger DR. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110Î´ inhibition as a potential therapeutic strategy. Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12165-70. doi:10.1073/pnas.1206118109. Epub 2012 Jun 11. PubMed PMID: 22689948; PubMed Central PMCID: PMC3409795.

---

# Drugs for schizophrenia (51)


---

# Overview, Summary, Prospects  (52)
